Avata Biosciences Holdings

Develops cannabinoid medicines for patients with epilepsy and other neurological diseases

London, United KingdomFounded 2022avatabio.comWebsite technologies

+ Add to sales board

Highlights

  • Young companyFounded 2022
  • New on EvolcAdded 2026-11-10

About Avata Biosciences Holdings

Avata Biosciences develops pharmaceutical-grade cannabinoid medicines using a process that turns water-insoluble active ingredients into water-soluble powder. Its products include capsule and aqueous-solution formulations, with programs for adult and pediatric focal epilepsy and schizophrenia.

The company is a clinical-stage pharmaceutical business. It lists offices in London, Phoenix and Carlton, Australia, and announced a co-development and licensing agreement for Japan and parts of Asia in 2025.

Product: Develops prescription cannabinoid medicines in capsule and aqueous-solution formulations for neurological conditions.

Jobs at Avata Biosciences Holdings

No open positions listed right now.

More biotech & pharma companies

  • Avaxmed

    Develops solid-dose vaccine and medication manufacturing and needle-free delivery technology for human and veterinary use
    Abingdon, United KingdomBiotech & pharmaFounded 2017
  • Aviadobio

    Develops gene therapies for patients with neurodegenerative diseases, including disorders affecting the brain and retina
    London, United KingdomBiotech & pharmaFounded 2019
  • Avianta Pharma

    Licenses and supplies essential medicines to online pharmacy networks
    Leamington Spa, United KingdomBiotech & pharmaFounded 2017
  • Avonchem Diagnostics

    Supplies chemicals, reagents, solvents and diagnostic tests to pharma, manufacturing and healthcare buyers in the UK
    Witney, United KingdomBiotech & pharmaFounded 2010
    New on Evolc
  • Axovia Therapeutics

    Gene therapies for people with ciliopathies, including Bardet-Biedl syndrome and genetic obesity
    London, United KingdomBiotech & pharmaFounded 2023
    Young companyNew on Evolc
  • Azadyne

    Pre-clinical drug developer targeting tRNA modification pathways to treat autoimmune and other diseases
    London, United KingdomBiotech & pharmaFounded 2018
    New on Evolc

All biotech & pharma companies →

Website technologies

Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.

Content delivery

  • CloudflareHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Content management

  • WixHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Frontend frameworks

  • ReactMedium confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Monitoring

  • SentryHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.